Journal of Cutaneous and Aesthetic Surgery
Print this page
Email this page
Small font size
Default font size
Increase font size
Home About us Current issue Archives Instructions Submission Subscribe Editorial Board Partners Contact e-Alerts Login 
GUIDELINES
Year : 2017  |  Volume : 10  |  Issue : 4  |  Page : 186-194

Standard guidelines of care: Performing procedures in patients on or recently administered with isotretinoin


1 Venkat Charmalaya, Centre for Advanced Dermatology and Postgraduate Training, Bengaluru, India
2 Department of Dermatology, Vikram Perfect Hospital, Mysuru, Karnataka, India
3 Department of Dermatology, Assam Medical College and Hospital, Dibrugarh, Assam, India
4 Cutis Skin and Laser Institute, Srinagar, Jammu and Kashmir, India
5 Disha Skin and Laser Institute, Thane, Maharashtra, India
6 Department of Dermatology, Father Muller Medical College, Mangaluru, Karnataka, India
7 Talwar Skin Centre, Lucknow, Uttar Pradesh, India
8 Department of Dermatology and Laser Surgery, Skin and Laser Clinic, Hyderabad, Telangana, India
9 Cutis Clinic, Calicut, Kozhikode, Kerala, India
10 Department of Dermatology, Institute of Naval Medicine, INHS Aswini, Mumbai, Maharashtra, India
11 Skinnovation Laser Clinic, New Delhi, India

Correspondence Address:
Venkataram Mysore
Venkat Charmalaya, Centre for Advanced Dermatology, Bengaluru 560040, Karnataka, India.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JCAS.JCAS_110_17

Rights and Permissions

Background: Currently, the standard protocol regarding the performance of procedures on patients receiving or having recently received isotretinoin (13-cis-retinoic acid) states that the procedures should not be performed. The recommendations in standard books and drug insert require discontinuation of isotretinoin for 6 months before performing cosmetic procedures, including waxing, dermabrasion, chemical peels, laser procedures, or incisional and excisional cold-steel surgery. These recommendations have been followed for over two decades despite little evidence for the stated increased risk of scarring. Objective: The Association of Cutaneous Surgeons (I) constituted a task force to review the evidence and to recommend consensus guidelines regarding the safety of skin procedures, including resurfacing, energy-device treatments, and dermatosurgical procedures in patients with concurrent or recent isotretinoin administration. Materials and Methods: Data were extracted from the literature through a PubMed search using the keywords “isotretinoin,” “safety,” “scarring,” “keloids,” “hypertrophic scarring,” and “pigmentation.” The evidence was then labeled and circulated to all members of task force for review. Results: The task force is of the opinion that there is insufficient evidence to support the current protocol of avoiding and delaying treatments in the patient group under consideration and recommends that the current practice should be discontinued.The task force concludes that performing procedures such as laser hair removal, fractional lasers for aging and acne scarring, lasers for pigmented skin lesions, fractional radio-frequency microneedling, superficial and medium-depth peels, microdermabrasion, dermaroller, biopsies, radio-frequency ablation, and superficial excisions is safe in patients with concurrent or recent isotretinoin administration.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1650    
    Printed44    
    Emailed0    
    PDF Downloaded269    
    Comments [Add]    

Recommend this journal